{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:22:12Z","timestamp":1791177732659,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-03984-2","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:43:34Z","timestamp":1743255814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Causes and prognosis of neovascular glaucoma after pars plana vitrectomy in patients with diabetic retinopathy"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaolu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyin","family":"wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"3984_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000431196","volume":"55","author":"SJ Havens","year":"2016","unstructured":"Havens SJ, Gulati V. Neovascular glaucoma. Dev Ophthalmol. 2016;55:196\u2013204.","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"3984_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41598-025-85667-y","volume":"15","author":"S Hwang","year":"2025","unstructured":"Hwang S, Hong EH, Kang MH, et al. Early postoperative bevacizumab for preventing neovascular glaucoma in phacovitrectomy for proliferative diabetic retinopathy. Sci Rep. 2025;15(1):1231.","journal-title":"Sci Rep"},{"issue":"9","key":"3984_CR3","doi-asserted-by":"publisher","first-page":"107641","DOI":"10.1016\/j.jdiacomp.2020.107641","volume":"34","author":"S Song","year":"2020","unstructured":"Song S, Yu X, Zhang P, Dai H. Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy. J Diabetes Complications. 2020;34(9):107641.","journal-title":"J Diabetes Complications"},{"issue":"7","key":"3984_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/IJG.0b013e31824d514a","volume":"22","author":"A Goto","year":"2013","unstructured":"Goto A, Inatani M, Inoue T, et al. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. J Glaucoma. 2013;22(7):572\u20136.","journal-title":"J Glaucoma"},{"key":"3984_CR5","doi-asserted-by":"crossref","unstructured":"Simha A, Braganza A, Abraham L et al. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013;(10):CD007920.","DOI":"10.1002\/14651858.CD007920.pub2"},{"key":"3984_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40942-016-0051-x","volume":"2","author":"GB Rodrigues","year":"2016","unstructured":"Rodrigues GB, Abe RY, Zangalli C, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016;2:26.","journal-title":"Int J Retina Vitreous"},{"issue":"8","key":"3984_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/IJG.0b013e3181997211","volume":"18","author":"S Yazdani","year":"2009","unstructured":"Yazdani S, Hendi K, Pakravan M, et al. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial. J Glaucoma. 2009;18(8):632\u20137.","journal-title":"J Glaucoma"},{"issue":"2","key":"3984_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s004170000235","volume":"239","author":"N Ogata","year":"2001","unstructured":"Ogata N, Ando A, Uyama M, et al. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 2001;239(2):87\u201395.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"3984_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/eye.2015.259","volume":"30","author":"LC Olmos","year":"2016","unstructured":"Olmos LC, Sayed MS, Moraczewski AL, et al. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond). 2016;30(4):463\u201372.","journal-title":"Eye (Lond)"},{"issue":"7","key":"3984_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0161-6420(82)34724-7","volume":"89","author":"LE Magargal","year":"1982","unstructured":"Magargal LE, Brown GC, Augsburger JJ, et al. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology. 1982;89(7):780\u20134.","journal-title":"Ophthalmology"},{"issue":"3","key":"3984_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ophtha.2009.07.031","volume":"117","author":"K Kriechbaum","year":"2010","unstructured":"Kriechbaum K, Bolz M, Deak GG, et al. High-resolution imaging of the human retina in vivo after scatter photocoagulation treatment using a semiautomated laser system. Ophthalmology. 2010;117(3):545\u201351.","journal-title":"Ophthalmology"},{"issue":"1","key":"3984_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-51411-6","volume":"9","author":"K Takayama","year":"2019","unstructured":"Takayama K, Someya H, Yokoyama H, et al. Risk factors of neovascular glaucoma after 25-gauge vitrectomy for proliferative diabetic retinopathy with vitreous hemorrhage: a retrospective multicenter study. Sci Rep. 2019;9(1):1\u20136.","journal-title":"Sci Rep"},{"issue":"12","key":"3984_CR13","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1517\/14712598.2012.721772","volume":"12","author":"SC Park","year":"2012","unstructured":"Park SC, Su D, Tello C. Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab. Expert Opin Biol Ther. 2012;12(12):1641\u20137.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"3984_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5301\/ejo.5000089","volume":"22","author":"E Wittstrom","year":"2012","unstructured":"Wittstrom E, Holmberg H, Hvarfner C, Andreasson S. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab. Eur J Ophthalmol. 2012;22(4):563\u201374.","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"3984_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3760\/cma.j.issn.0366-6999.20130011","volume":"126","author":"MW Zhou","year":"2013","unstructured":"Zhou MW, Wang W, Huang WB, et al. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J (Engl). 2013;126(8):1412\u20137.","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"3984_CR16","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1167\/iovs.12-11507","volume":"54","author":"M Zhou","year":"2013","unstructured":"Zhou M, Chen S, Wang W, et al. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab. Invest Ophthalmol Vis Sci. 2013;54(6):3874\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3984_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3928\/1542-8877-19950901-09","volume":"26","author":"P Senn","year":"1995","unstructured":"Senn P, Schipper I, Perren B. Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surg Lasers. 1995;26(5):420\u20138.","journal-title":"Ophthalmic Surg Lasers"},{"key":"3984_CR18","first-page":"307","volume":"79","author":"E Stefansson","year":"1981","unstructured":"Stefansson E, Landers MB 3rd, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc. 1981;79:307\u201334.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"3984_CR19","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0886-3350(02)01354-8","volume":"28","author":"TY Chung","year":"2002","unstructured":"Chung TY, Chung H, Lee JH. Combined surgery and sequential surgery comprising phacoemulsification, pars plana vitrectomy, and intraocular lens implantation: comparison of clinical outcomes. J Cataract Refract Surg. 2002;28(11):2001\u20135.","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"3984_CR20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0161-6420(03)00454-8","volume":"110","author":"JM Lahey","year":"2003","unstructured":"Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology. 2003;110(7):1335\u20139.","journal-title":"Ophthalmology"},{"issue":"10","key":"3984_CR21","doi-asserted-by":"publisher","first-page":"e110531","DOI":"10.1371\/journal.pone.0110531","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Chen S, Jiang F, et al. Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy. PLoS ONE. 2014;9(10):e110531.","journal-title":"PLoS ONE"},{"issue":"10","key":"3984_CR22","doi-asserted-by":"publisher","first-page":"e6263","DOI":"10.1097\/MD.0000000000006263","volume":"96","author":"JW Kwon","year":"2017","unstructured":"Kwon JW, Jee D, La TY. Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy. Med (Baltim). 2017;96(10):e6263.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3984_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12886-016-0327-9","volume":"16","author":"Y Sun","year":"2016","unstructured":"Sun Y, Liang Y, Zhou P, et al. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmol. 2016;16(1):150.","journal-title":"BMC Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03984-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:08:39Z","timestamp":1743271719000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3984"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03984-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of Hebei Eye Hospital, China. Written informed consent was obtained from each patient or their parents (for children\u2009<\u200918 years of age) prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}